Intrinsic Value of S&P & Nasdaq Contact Us

Ingevity Corporation NGVT NYSE

NYSE • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
$282.54
+280.7%
Analyst Price Target
$76.67
+3.3%

Ingevity Corporation (NGVT) generated $97.1M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $23.6M, free cash flow was $73.5M.

Free cash flow margin was 28.8% of revenue. Cash conversion ratio was -1.15x, suggesting some earnings are non-cash.

The company returned $31.1M in share buybacks to shareholders during the quarter.

Criteria supported by this page:

  • HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (60/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was -1.15x suggests some earnings are non-cash items

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
72/100
Price-to-Earnings & upside
→ Valuation
FUTURE
67/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
60/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Ingevity Corporation Cash Flow History
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Operating Cash Flow $331.2M$97.1M$129.7M$79M$25.4M
Capital Expenditure $-57.7M$-23.6M$-11.9M$-12.2M$-10M
Free Cash Flow $273.5M$73.5M$117.8M$66.8M$15.4M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message